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Abstract
Background: The aim of the study was to estimate and compare the 8-year cumulative incidence of diabetes
mellitus (DM) among Sami and non-Sami inhabitants of rural districts in Northern Norway.
Methods: Longitudinal study based on linkage of two cross-sectional surveys, the SAMINOR 1 Survey (2003–2004)
and the SAMINOR 2 Clinical Survey (2012–2014). Ten municipalities in rural Northern Norway were included in the
study. DM-free participants aged 30 and 36–71 years in SAMINOR 1 were followed from 2 years after SAMINOR 1 to
attendance in SAMINOR 2. The average follow-up time was 8.1 years. Of 5875 subjects who had participated in
SAMINOR 1 and could potentially be followed to SAMINOR 2, 3303 were included in the final analysis. Self-reported
DM and/or HbA1c ≥ 6.5% were used to identify incident cases of DM.
Results: At baseline, body mass index (BMI) and waist-to-height ratio (WHtR) were higher among Sami than among
their non-Sami counterparts. After 8 years of follow-up, 201 incident cases of DM were identified (6.1% both Sami
and non-Sami subjects). No statistically significant difference was observed in the cumulative incidence of DM
between the Sami and non-Sami.
Conclusions: No statistically significant difference in the 8-year cumulative incidence of DM among Sami and non-
Sami was observed, although Sami men and women had higher baseline BMI and WHtR.
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Background
Type 2 diabetes mellitus (DM) is one of the most preva-
lent and disabling chronic diseases affecting millions of
people worldwide [1]. Indigenous peoples throughout
the world are facing an unprecedented epidemic of type
2 DM [2], but publications concerning the incidence of
the disease among these groups are rather sparse. This
could in part be due to the need for costly and cumber-
some cohort studies or the lack of available robust data
from national registries.
The Sami are an indigenous people, who for centuries
have inhabited northern parts of Norway, Sweden, and
Finland, and the Kola Peninsula of Russia. Sami people
might possess genes that either predispose them to or
protect them against development of diseases like DM.
Furthermore, they have their own culture, diet, and so
forth, which might play a role in increasing or decreas-
ing the risk of DM. Internationally, studies have shown a
striking difference in the prevalence and incidence of
diabetes mellitus between indigenous populations and
majority populations [3–6]. Higher incidence and preva-
lence of type 2 DM among indigenous peoples, in com-
parison to the benchmark populations, seems to be a
shared phenomenon worldwide [2]. For example, the
age-standardised incidence of type 2 DM of 1814 Aus-
tralian Aboriginal and Torres Strait Islander adults from
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1999 to 2007 was reported to be 30.5 in 1000 person-
years. This incidence rate is nearly four times higher
than that for the non-Indigenous population and 50%
higher than the incidence reported 10 years ago in Aus-
tralian Aboriginals [7].
Previous research based on data from 24 municipal-
ities in the SAMINOR 1 Survey (2003–2004), showed
no statistically significant difference between Sami
and non-Sami in the prevalence of DM, defined by
self-report and/or non-fasting plasma glucose ≥11.1
mmol/L [8, 9]. However, a study using data from the
SAMINOR 2 Clinical Survey (2012–2014), found
higher prevalence of both pre-diabetes and type 2
DM among Sami people, when self-report and/or
HbA1c ≥ 6.5% was used to define diabetes cases [10].
However, due to the different population samples and
diagnostic methods applied, it is not possible to ascer-
tain whether the higher diabetes prevalence in SAMI-
NOR 2 among Sami participants reflects a higher
incidence of diabetes over the last decade. A study
from the SAMINOR 1 Survey, showed higher obesity
prevalence and a more sedentary lifestyle among Sami
women [11]. Therefore, they are expected to have
higher risk of developing type 2 DM.
To our knowledge, there are no previous studies inves-
tigating the incidence of DM in the Sami population of
rural municipalities in Northern Norway.
The aim of this study is to measure and compare the
8-year cumulative incidence of DM among Sami and
non-Sami inhabitants of rural districts in Northern
Norway.
Methods
In 2003–2004, the Centre for Sami Health Research at
UiT The Arctic University of Norway, in collaboration
with the Norwegian Institute of Public Health, con-
ducted the SAMINOR 1 Survey (hereafter referred to as
SAMINOR 1) [12]. This survey included 24 mostly rural
municipalities and districts in Northern and Central
Norway with a considerable proportion of Sami
inhabitants.
In 2012–2014, the Centre for Sami Health Research
undertook a two-part second survey, the SAMINOR 2
Questionnaire Survey [13] and the SAMINOR 2 Clinical
Survey [14]. The present analyses are based on data
from the SAMINOR 2 Clinical Survey (hereafter referred
to as SAMINOR 2), which, similarly to SAMINOR 1,
consisted of self-administered questionnaires, a clinical
examination, and analysis of blood samples. The survey
was conducted in 10 rural municipalities in Finnmark,
Troms, and Nordland counties, all previously included
in SAMINOR 1: Kautokeino, Karasjok, Tana, Nesseby,
Porsanger, Lyngen, Storfjord, Kåfjord, Skånland, and
Evenes (Fig. 1). The survey was conducted in 10 rural
municipalities in Finnmark, Troms, and Nordland coun-
ties, all previously included in SAMINOR 1: Kautokeino,
Karasjok, Tana, Nesseby, Porsanger, Lyngen, Storfjord,
Kåfjord, Skånland, and Evenes (Fig. 1).
The included municipalities were chosen due to a high
number of Sami inhabitants. The invitees were informed
that the study aimed primarily to increase knowledge
about health, diseases, and living conditions in regions
with Sami and Norwegian populations and provide a
health profile for their county/municipality, in addition
to getting personal feedback of their own health status.
Study sample
In SAMINOR 1, a total of 27,987 subjects, aged 30 or
36–79 years were invited, and 16,865 participated
(60.6%). In SAMINOR 2, 12,455 subjects, aged 40–79
years, were invited to take part, and 6004 participated
(48.2%), whereof 3872 persons had previously partici-
pated in SAMINOR 1. The present analyses are based
on longitudinal data including individuals participating
in both SAMINOR 1 and SAMINOR 2 who did not fill
the exclusion criteria detailed below.
We lack information about those invited to SAMINOR
2, who had also participated in SAMINOR 1 but who
failed to participate in SAMINOR 2, as a linkage is only
allowed for those who participated in both surveys.
Therefore, loss to follow-up is described based on
SAMINOR 1 participants who would have been invited
to SAMINOR 2, given that they had not died or moved
from the 10 studied municipalities prior to invitation to
SAMINOR 2. There were 11,558 invitees to SAMINOR
1, who, according to their birth year and municipality,
would have been invited to SAMINOR 2, given that they
had not moved or died. Of these, 6450 (55.8%) partici-
pated in the SAMINOR 1 clinical examinations, of
whom 6408 gave their consent to register linkages. The
two data files were merged by Statistics Norway, using
the unique 11-digit personal identification number
assigned to all subjects residing in Norway.
Figure 2 displays the population and exclusions ap-
plied. Among the 6408 individuals, the following were
excluded: 169 due to missing initial questionnaire; 2 due
to missing main questionnaire (containing diabetes in-
formation); and 27 due to missing ethnicity information
in SAMINOR 1. Based on self-report and random (non-
fasting) plasma glucose (RPG) ≥11.1 mmol/L measure-
ment in SAMINOR 1, 260 prevalent cases of DM were
excluded. To ensure exclusion of prevalent cases, in total
75 participants were excluded, as, in SAMINOR 2, they
reported the date at the time of DM diagnosis as prior
to (n = 52), at the same time as (n = 6) or during the first
2 years after participating in SAMINOR 1 (n = 17, 2
years wash-out period). Of the remaining 5875 persons,
11 were not included in the final analysis due to missing
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main questionnaire (n = 10) or HbA1c measurement
(n = 1) in SAMINOR 2. A total of 2561 did not partici-
pate in SAMINOR 2 as they had died, moved out of the
included municipalities during the follow-up period, or
were not willing or able to participate in SAMINOR 2.
Hence, 3303 individuals (follow-up rate: 56.2%) were in-
cluded in the analysis (Fig. 2).
The data collection for SAMINOR 1 took place over
two calendar years and over three calendar years for
SAMINOR 2, and the municipalities were not visited in
the same order in the two surveys. Thus, the time span
between the two examinations varied from 8 to 11 years,
with a mean of 10.1 years. The merged file contains indi-
viduals born in the period 1933–1968 and in 1973, who
were aged 30 and 36–71 years in SAMINOR 1 and 40–
41 and 44–79 years in SAMINOR 2.
Blood sampling
In both SAMINOR 1 and 2, blood samples were taken
by venipuncture at normal venous pressure with the par-
ticipant in a seated position. In SAMINOR 1, blood
samples were mailed directly to the laboratory for
analysis. Among the included analyses was RPG. The ap-
plied methods and procedures in SAMINOR 1 are de-
scribed in detail elsewhere [12]. In SAMINOR 2,
glycated haemoglobin (HbA1c) was measured immedi-
ately on site from whole blood, using DCA Vantage™
(Siemens Medical Solutions Diagnostics, Tarrytown, NY,
USA). In SAMINOR 1, HbA1c was not measured.
Ethnicity
Ethnic information was collected through self-report in
SAMINOR 1. The questions were: “What language(s)
do/did you, your parents and your grandparents use at
home?”, “What is your, your father’s and your mother’s
ethnic background?”, and “What do you consider your-
self to be?” For all items, the response options were:
“Norwegian”, “Sami”, “Kven”, and “Other”. The questions
were to be answered separately for each relative, and
multiple answers were allowed. Sami ethnicity was de-
fined based on two criteria: 1) self-identification as a
Sami, and 2) a Sami language connection. Sami self-
identification was regarded as fulfilled if the respondent
considered him/herself to be Sami or reported having a
Fig. 1 Map of Northern Norway, Sápmi, and the included municipalities in the SAMINOR 2 Clinical Survey (2012–2014). Published with permission
from Centre for Sami Health Research
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Sami ethnic background. Sami language connection was
defined if at least one grandparent, parent, or the partici-
pant him/herself spoke a Sami language at home. Partic-
ipants who fulfilled both criteria were categorised as
Sami. All other participants were categorised as non-
Sami.
Diabetes mellitus
In SAMINOR 1, both questionnaire information and
RPG levels were used to categorized participants as hav-
ing DM. The question concerning diabetes was: “Do you
have, or have you had, diabetes? (yes/no)”. Those who
answered “yes”, or who had RPG levels of 11.1 mmol/L
or higher, were considered prevalent cases of DM.
In SAMINOR 2, the question was: “Have you ever
been diagnosed with diabetes (elevated blood sugar
levels)? (yes/no)”. Missing self-report of DM was classi-
fied as “no”. Participants who answered “yes” or had
HbA1c ≥ 6.5% were categorised as incident cases.
Risk factors for type 2 DM
All potential risk factors for DM included in the present
study were measured at the start of the study, i.e., in
SAMINOR 1.
Fig. 2 Flow chart demonstrating persons included for final analysis
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Height (cm) and weight (kg) were measured using an
electronic height and weight scale, with participants
wearing light clothing without shoes. Body mass index
(BMI) was calculated as weight in kilograms, divided by
the square of the height in metres (kg/m2). Waist cir-
cumference (WC) was measured in centimetres at the
umbilicus, with the participant standing and breathing
normally. Waist-to-height ratio (WHtR) was calculated
as waist circumference divided by height.
Those who reported in the questionnaire that at least
one of their parents, siblings or offspring had DM were
regarded as having a positive family history of DM.
Marital status (married vs single, widowed/widower, di-
vorced or separated), education (highly educated with
more than 12 years of education vs lower education),
cigarette smoking (current smoker vs ex-smoker or
never-smoker), alcohol drinking (drinking at least once a
week vs drinking less often), annual family gross income
(lower than 451,000 Norwegian Kroner vs higher in-
come) were also assessed.
Hopkins Symptom Checklist (SCL-10) was used for
measuring mental distress [15]. Ten items relevant for
mental health are included in the SCL-10: experiencing
fear, frightened/ anxiousness, faintness/dizziness, tense-
ness/upset, insomnia/sleeplessness, easily blaming your-
self, being dejected/melancholia, being useless or of little
value, experiencing everything as a struggle, being hope-
less regarding the future. Each question was answered
on a four-point scale ranging from 1 = “Not affected” to
4 = “Extremely affected”. In total, 418 participants had at
least one missing answer to one of the mentioned ten
questions. Imputation was performed for those with one
(n = 130) or two (n = 31) missing answers, by assigning
the mean values of the respective questions to them, as
described by Strand et al. [16]. For records with three or
more missing responses, the SCL-10 score was not cal-
culated. The mean of the ten scores was then calculated
for each participant, by dividing the sum of the scores
by ten. A SCL-10 score over 1.85 is considered indicative
of mental distress [15, 16].
Participants scored their leisure-time physical activity
during the past year on a four-point scale: 1) “reading,
watching TV, or other sedentary activities”; 2) “walking,
cycling, or similar forms of exercise at least 4 h a week”;
3) “at least 4 h a week of recreational sports, heavy gar-
dening, etc.”; and 4) “hard training or sports competi-
tions regularly and several times a week” [17]. Those
who reported reading, watching TV, or other sedentary
activities were regarded as inactive.
Statistical analysis
Data management and statistical analysis were per-
formed using Stata version 15.0 (Stata Corp., College
Station, TX, USA). All tests were two-sided with a 5%
significance level.
Those who were included in the analysis were com-
pared with those we would wish to follow up but were
not able to include (due to death, emigration, or lack of
participation or insufficient information in SAMINOR 2)
with regard to the available baseline characteristics and
risk factors for DM (Table 1). Differences in mean age,
BMI, WC, and WHtR were tested by two-sample t-tests.
For the categorical variables, Sami ethnicity, having posi-
tive family history of DM, marital status, being highly
educated, SCL-10 score > 1.85 (mental distress), smok-
ing, drinking alcohol, having low income, and being in-
active in leisure-time, the groups were compared using
Pearson’s χ2 tests. The same variables were compared
for Sami vs non-Sami subjects included in the analyses
(Table 2).
Those who were categorised as having DM in SAMI-
NOR 2, but not in SAMINOR 1 or the first 2 years after
it, were regarded as incident cases of DM, and, by divid-
ing the number of incident cases by the number of DM-
free participants in SAMINOR 1 (at-risk individuals),
the approximate 8-year cumulative incidence of DM was
estimated.
Multiple logistic regression analysis was used to assess
the effect of ethnicity (Sami vs non-Sami), as well as
various risk factors, on the development of DM (Table 3)
. At first, the effect of each potential risk factor was
assessed using univariable regression analyses. Then the
variables with significant ORs in the univariable analyses
were included together with ethnicity and sex in a multi-
variable logistic regression analysis. Of BMI, WC and
WHtR only WHtR was put into the multivariable ana-
lysis as the three variables have a large correlation with
each other. Family history of DM was not put in the
multivariable analysis to avoid over-adjustment (Table 3)
.
Ethics
The SAMINOR Study was approved by the Norwegian
Data Inspectorate and by the Regional Committees for
Medical and Health Research Ethics North (REC North).
The committee also approved the present study, with
approval number 2016/173. All participants gave written
informed consent for medical research and to have their
data linked to other registers or surveys. The study was
also approved by the SAMINOR Project Board.
Results
Compared to subjects who took part in SAMINOR 1,
but were not followed up, subjects who participated in
both surveys were on average older, and more likely to
be married and report Sami ethnicity. Furthermore,
those included in the follow-up analyses were more
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physically active, and less likely to be current smokers,
reporting mental disorders and having low income
(Table 1).
Table 2 shows some baseline characteristics of DM-free
individuals in SAMINOR 1 who were followed up until
SAMINOR 2. In both sexes, Sami had higher mean WHtR
and BMI compared to non-Sami. Mean WC was higher
among non-Sami men, while no statistically significant dif-
ference was observed in the mean WC between Sami and
non-Sami women. Among women, more Sami than non-
Sami were considered inactive (Table 2).
A total of 201 incident cases of DM were identified in
SAMINOR 2, based on self-report (n = 138) or HbA1c ≥
6.5% (without self-report) (n = 63). We noted that all the
self-reported cases had HbA1c ≥ 6.5% (results not
shown). This number corresponds to a 6.1% (95% confi-
dence interval: 5.3–6.9) 8-year cumulative incidence of
DM. The 8-year cumulative incidence of diabetes among
Sami and non-Sami men was 7.1% (95% confidence
interval: 5.1–9.5) and 6.5% (95% confidence interval:
4.9–8.3) respectively. Corresponding values for Sami and
non-Sami women were 5.3% (95% confidence interval:
Table 1 Characteristics of individuals we were able to follow-up, compared to those who were not followed up, among those who
participated in SAMINOR 1 (2003–2004) and were eligiblea for SAMINOR 2 (2012–2014), by sex (N = 5875). Numbers are mean
(standard deviation) for continuous variables and percent (number of subjects) for categorical variables
Included in the follow-up analysis Not included in the follow-up analysis p-value
Men N = 1447 N = 1307
Age (year) 52.4 (8.7) 51.2 (9.8) < 0.01
Body mass index (kg/m2) 27.5 (3.5) 27.6 (4.2) 0.42
Waist circumference (cm) 92.3 (9.3) 93.0 (10.9) 0.07
Waist-to-height ratio 0.534 (0.054) 0.537 (0.064) 0.10
Sami ethnicity (%) 40.2 (581) 32.7 (866) < 0.01
Family history of DMb (%) 19.4 (280) 18.2 (238) 0.44
Marriedc (%) 64.5 (933) 52.8 (690) < 0.01
Education> 12 years (%) 32.8 (458) 30.7 (381) 0.26
SCL-10 score > 1.85 (%) 5.3 (72) 9.5 (114) < 0.01
Current smokerd (%) 28.8 (416) 39.5 (516) < 0.01
Alcohole (%) 30.7 (444) 31.1 (407) 0.80
Low-incomef (%) 57.0 (825) 61.5 (804) 0.02
Inactiveg (%) 18.8 (272) 23.1 (302) 0.01
Women N = 1856 N = 1265
Age (year) 51.6 (9.0) 50.7 (10.1) < 0.01
Body mass index (kg/m2) 27.4 (4.6) 27.6 (4.9) 0.38
Waist circumference (cm) 84.0 (11.2) 84.2 (11.8) 0.08
Waist-to-height ratio 0.526 (0.074) 0.527 (0.076) 0.40
Sami ethnicity (%) 39.5 (733) 29.4 (372) < 0.01
Family history of DMb (%) 23.2 (430) 21.8 (276) 0.38
Marriedc (%) 66.0 (1225) 58.2 (736) < 0.01
Education> 12 years (%) 38.0 (674) 36.3 (428) 0.34
SCL-10 score > 1.85 (%) 8.4 (141) 11.5 (130) < 0.01
Current smokerd (%) 30.6 (568) 40.9 (517) < 0.01
Alcohole (%) 19.7 (365) 20.5 (259) 0.58
Low-incomef (%) 58.7 (1090) 62.7 (793) 0.03
Inactiveg (%) 19.1 (355) 22.9 (289) 0.01
aLiving in the 10 SAMINOR 2 municipalities at time of SAMINOR 1 with relevant year of birth
bThose who had at least one with DM among father, mother, siblings or children
cMarried vs single, widow/widower, divorced, or separated
dCurrent smokers vs former smokers or never-smokers
eDrinking alcohol at least once a week
fYearly gross income of the household less than 451,000 Norwegian Kroner
gLeisure-time activities include reading, watching TV or other sedentary activities
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3.8–7.2) and 5.8% (95% confidence interval: 4.5–7.3%)
respectively.
In univariable analyses, higher age, BMI, WC, and
WHtR, lower education and having positive family his-
tory of DM significantly increased the odds for incident
DM (Table 3). Women had statistically significantly
lower incidence of DM when adjusting for ethnicity, age,
WHtR and education. No statistically significant
difference was found between Sami and non-Sami in the
odds of 8-year cumulative incidence of DM.
Discussion
The present study is the first to estimate the cumulative
incidence of DM among Sami and non-Sami inhabitants
of Northern Norway. After 8 years of follow-up, 201
(6.1%) incident cases of DM were identified, based on
self-report and/or HbA1c ≥ 6.5%. The 8-year cumulative
incidence of DM was not statistically significantly differ-
ent between Sami and non-Sami.
Of 5875 SAMINOR 1 participants who were eligible
to participate in SAMINOR 2, 3303 were included in the
follow-up analysis. To assess the risk of selection bias,
we compared some relevant and available risk factors for
DM between those who were included in the analysis
and those who were not. Although those who were not
included in the final analysis were on average younger,
the age discrepancy was only around 1 year, which may
not have affected the estimated cumulative incidence of
DM. Not being married, being a smoker, having a higher
SCL-10 score (mental distress indicator), having lower
income and having lower level of leisure-time physical
activity, were some attributes of those who were not in-
cluded in the analysis. In the second survey of the
Tromsø Study, it was found that non-participants were
over-represented among young and unmarried men [18].
Results from the Tromsø Study indicate lower mortality
in subjects who attended several surveys rather than
only one [19]. Results from similar studies in Norway in-
dicate that non-participants have higher levels of chronic
diseases and higher mortality rates; furthermore, non-
participants are more likely to be receiving disability
pension and belonging to lower socioeconomic groups
[20, 21]. On the other hand, BMI, WC, WHtR (indica-
tors of obesity) and having a positive family history of
DM (an indicator of genetic predisposition to DM) were
not statistically significantly different between those in-
cluded in our analysis and those not, making it less likely
that the two groups were systematically different with
regard to the risk of DM.
If loss to follow-up is due to the outcome (DM), its
complications or diseases with shared risk factors (e.g.
cardiovascular diseases), the cumulative risk is underesti-
mated (competing risk effect) [22]. Our dataset was not
linked to the Cause of Death Registry, so we do not have
direct information about the number and causes of
death of those who died during the follow-up period. It
is unlikely that a participant who contracted DM during
the follow-up period and died of the disease itself or its
late complications. On the other hand, deaths due to
competing risks (like cardiovascular diseases) inevitably
lead to underestimation of the cumulative incidence of
DM. Based on numbers from Statistics Norway, one can
Table 2 Baseline characteristics of diabetes-free participants in
SAMINOR 1 (2003–2004) followed-up to SAMINOR 2 (2012–
2014), N = 3303. Numbers are mean (standard deviation) for
continuous variables (age, body mass index, waist
circumference, and waist-to-height ratio) and percent (number
of subjects) for categorical variables (family history of DM,
married, education> 12 years, SCL-10 score > 1.85, alcohol, low-
income, and inactive)
Sami Non-Sami p-value
Men N = 581 N = 866
Age (year) 51.8 (8.8) 52.8 (8.7) 0.04
Body mass index (kg/m2) 27.8 (3.8) 27.3 (3.3) 0.02
Waist circumference (cm) 91.7 (9.8) 92.8 (9.0) 0.03
Waist-to-height ratio 0.540 (0.060) 0.529 (0.050) < 0.01
Family history of DMa (%) 20.5 (119) 18.6 (161) 0.37
Marriedb (%) 59.2 (344) 68.0 (589) < 0.01
Education> 12 years (%) 32.6 (184) 32.9 (274) 0.89
SCL-10 score > 1.85 (%) 6.3 (34) 4.6 (38) 0.17
Current smokerc (%) 29.6 (172) 28.2 (244) 0.55
Alcohold (%) 27.4 (159) 32.9 (285) 0.02
Low-incomee (%) 60.2 (350) 54.8 (475) 0.04
Inactivef (%) 20.3 (118) 17.8 (154) 0.23
Women N = 733 N = 1123
Age (year) 50.7 (8.9) 52.1 (8.9) < 0.01
Body mass index (kg/m2) 28.0 (4.8) 27.0 (4.5) < 0.01
Waist circumference (cm) 84.5 (11.3) 83.6 (11.2) 0.11
Waist-to-height ratio 0.539 (0.075) 0.516 (0.072) < 0.01
Family history of DMa (%) 24.6 (180) 22.3 (250) 0.25
Marriedb (%) 60.3 (442) 69.7 (783) < 0.01
Education> 12 years (%) 42.7 (298) 35.0 (376) < 0.01
SCL-10 score > 1.85 (%) 9.0 (60) 8.0 (81) 0.47
Current smokerc (%) 31.6 (232) 29.9 (336) 0.43
Alcohold (%) 14.3 (105) 23.1 (260) < 0.01
Low-incomee (%) 61.0 (447) 57.3 (643) 0.11
Inactivef (%) 25.0 (183) 15.3 (172) < 0.01
aThose who had at least one with DM among father, mother, siblings
or children
bMarried vs single, widow/widower, divorced, or separated
cCurrent smokers vs former smokers or never-smokers
dDrinking alcohol at least once a week
eYearly gross income of the household less than 451,000 Norwegian Kroner
fLeisure-time activities include reading, watching TV or other
sedentary activities
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expect there to have been around 330 deaths from 2001
to 2011 (10 years) in a group of 5875 persons with simi-
lar age distribution to those of our participants (calcula-
tions not shown) [23].
According to the Norwegian Institute of Public Health,
cancers are the leading cause of death in people with a
similar age span to those of our participants, followed by
cardiovascular diseases (mutual risk factors for DM)
[24]. Competing risks become more important with the
increasing age of the population under study (increased
risk of multimorbidity). As the mean baseline age of
both groups, those that were followed up and those that
were not, was around 52 years, and there were relatively
few expected deaths (330 deaths totally), it is not
thought that competing risks have substantially affected
our estimate of the cumulative incidence of DM. Fur-
thermore, studies have shown minimal or no difference
between Sami and non-Sami individuals in the distribu-
tion of risk factors for cardiovascular diseases and/or the
risk of acute myocardial infarction or cerebral stroke
[25, 26]. We do not have information on the participants
in SAMINOR 1, who, due to emigration, were not in-
cluded in the final analysis, but they were few, and it is
unlikely that they had any impact on the conclusions.
At the end of the follow-up period (SAMINOR 2),
self-reported DM and/or HbA1c ≥ 6.5% was used to
identify incident cases of DM. This HbA1c cut-off is rec-
ommended by the American Diabetes Association, as
well as the Norwegian Directorate of Health [27, 28],
and is being largely applied in clinical practice. Accord-
ing to the Tromsø OGTT study, an HbA1c cut-off ≥6.5%
provides sensitivity and specificity of around 35 and
97%, respectively [29]. The low performance of the test
leads to substantial misclassification of DM, but it must
be assumed to be unrelated to categorization as a Sami
or not.
The questionnaire applied in the present study was
not validated. However, the sensitivity and positive pre-
dictive value of self-reported DM were reported as 86.7
and 73.4%, respectively, in the CADEUS study in France,
using medical records as standard [30]. The validity of
self-reported DM in the HUNT 1 Survey was reported
to be excellent by comparison with the general practi-
tioners’ records, with positive and negative predictive
values of 96 and 99.7%, respectively [31].
The lack of statistically significant difference in the 8-
year cumulative incidence of DM between Sami and
non-Sami might be explained by the misclassifications or
the relatively small study sample size. Similar standards
of living, high awareness about lifestyle diseases like type
2 DM and fair access to healthcare services for both eth-
nic groups in the study municipalities, are other possible
explanations.
According to a recently published cohort study, the es-
timated prevalence of diagnosed type 2 DM for all resi-
dents in Norway aged 30 to 89 years increased from
4.9% in year 2009 to 6.1% in 2014 [32]. Nevertheless, the
incidence rate of type 2 DM decreased significantly from
609 cases per 100,000 person-years in 2009 to 398 cases
per 100,000 in 2014, an annual reduction of 10.1%. Our
estimated cumulative incidence of DM (6.1% in 8 years
or around 762 cases in 100,000 participants in a year) is
comparable to the reported 609 cases per 100,000
person-years in year 2009. It should be kept in mind that
our estimate included all types of DM, while the men-
tioned study reported known cases of type 2 DM only.
However, due to the age of the new cases, they must be
expected to be mainly type 2 DM. In the HUNT Study
(from 1995 to 1997 to 2006–2008), the 11-year cumula-
tive incidence of any diabetes was around 4.5% among
adults (20 ≤ age < 70) using self-report, RPG ≥ 11.1
mmol/L, fasting plasma glucose ≥7mmol/L, HbAc1 ≥
6.5% or 2-h 75 g OGTT ≥11.1 mmol/L [31]. The differ-
ent age span of participants in the HUNT Study is the
Table 3 Univariable and multivariable odds ratios (OR) with
95% confidence interval (95% CI) for incident cases of diabetes
mellitus (DM) for various possible risk factors for DM. SAMINOR
1 (2003–2004) and SAMINOR 2 (2012–2014), N = 3303
Models OR (95% CI) p-value
Sami ethnicity 1.01 (0.75–1.34) 0.96
age 1.03 (1.01–1.05) < 0.01
sex (female) 0.83 (0.62–1.01) 0.19
BMIa 1.18 (1.15–1.22) < 0.01
WCb 1.07 (1.06–1.08) < 0.01
WHtRc 1.12 (1.10–1.15) < 0.01
education (year) 0.92 (0.88–0.96) < 0.01
inactivityd 1.32 (0.94–1.86) 0.10
alcohole 0.73 (0.51–1.04) 0.08
smokingf 0.98 (0.71–1.33) 0.89
mental distressg 0.69 (0.39–1.37) 0.29
family history of DMh 2.77 (2.07–3.73) < 0.01
ethnicity+age + sex+
WHtR+education
Sami: 0.81 (0.59–1.11) 0.20
age: 1.01 (0.99–1.02) 0.46
sex (female): 0.71 (0.52–0.97) 0.03
WHtR: 1.13 (1.10–1.15) < 0.01
education: 0.96 (0.92–1.01) 0.12
aBMI: body mass index (kg/m2)
bWC: waist circumference (cm)
cWHtR: waist-to-height ratio. In order to help understanding, this variable is
multiplied by 100
dLeisure-time physical activity includes reading, watching TV or other
sedentary activities
eDrinking alcohol at least once a week vs drinking alcohol less often
fCurrent smokers vs ex-smokers and never-smokers
gSCL-10 score > 1.85
hThose who had at least one with DM among father, mother, siblings
or children
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most likely explanation for the difference between our
results and those from the HUNT Study.
Results from the present study, as well as results from
our previous studies, which found either no or not a
marked ethnic difference in the incidence or prevalence
of DM between Sami and non-Sami people in Norway
[8–10], imply substantial better conditions for Sami
people in Norway, compared with those of other indi-
genous peoples throughout the world. This is probably
due to the Sami enjoying quite similar living and health-
care standards to those of other Norwegian citizens.
Strengths and limitations
Some of the strengths of the present study lie in the ap-
plication of a comprehensive questionnaire and the use
of trained personnel, enabling us to obtain copious
amounts of information on several aspects of living and
health-related conditions, as well as the use of HbA1c,
in addition to self-report, to ascertain DM. The present
study is the first longitudinal study to measure the cu-
mulative incidence of DM in Sami-inhabited regions in
Norway.
A suboptimal participation rate, relatively small sample
size, limited number of included municipalities, non-
fasting glucose measurements, lack of sufficient dietary
information, no differentiation between types of DM,
lack of linkage to national health registers such as pre-
scription databases, the Cause of Death Register, or dis-
charge register, are limitations of the present study. As a
large number of people were included, confirmation of
diabetes diagnosis with 2-h post-prandial glucose meas-
urement was not feasible. It is also a limitation that we
lack information about which of the SAMINOR 1 partic-
ipants were actually invited to SAMINOR 2.
We did not have reliable data on the exact time of
diagnosis/occurrence of the disease, which made calcula-
tion of the incidence rate of DM impossible.
Conclusions
We observed no ethnic difference in the 8-year cumula-
tive incidence of DM, although mean WHtR and BMI
were higher among Sami than non-Sami participants of
both sexes. There may be a need for larger studies in the
future, to track and elucidate any ethnic difference in
the cumulative incidence or incidence rate of DM.
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